These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1923592)

  • 1. [Iron transport and role of pyoverdines in infectivity of Pseudomonas aeruginosa. Therapeutic incidences].
    Abdallah MA; Hennard C; Linget C; Ocaktan A
    Pathol Biol (Paris); 1991 Jun; 39(6):600-5. PubMed ID: 1923592
    [No Abstract]   [Full Text] [Related]  

  • 2. Siderophore-mediated iron uptake in fluorescent Pseudomonas: characterization of the pyoverdine-receptor binding site of three cross-reacting pyoverdines.
    Meyer JM; Geoffroy VA; Baysse C; Cornelis P; Barelmann I; Taraz K; Budzikiewicz H
    Arch Biochem Biophys; 2002 Jan; 397(2):179-83. PubMed ID: 11795869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations.
    De Vos D; De Chial M; Cochez C; Jansen S; Tümmler B; Meyer JM; Cornelis P
    Arch Microbiol; 2001 May; 175(5):384-8. PubMed ID: 11409549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.
    Lamont IL; Konings AF; Reid DW
    Biometals; 2009 Feb; 22(1):53-60. PubMed ID: 19130260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copurification of the FpvA ferric pyoverdin receptor of Pseudomonas aeruginosa with its iron-free ligand: implications for siderophore-mediated iron transport.
    Schalk IJ; Kyslik P; Prome D; van Dorsselaer A; Poole K; Abdallah MA; Pattus F
    Biochemistry; 1999 Jul; 38(29):9357-65. PubMed ID: 10413510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa: a bacterium with multiple personalities].
    Merino LA
    Rev Argent Microbiol; 2007; 39(3):143. PubMed ID: 17987848
    [No Abstract]   [Full Text] [Related]  

  • 7. The binding mechanism of pyoverdin with the outer membrane receptor FpvA in Pseudomonas aeruginosa is dependent on its iron-loaded status.
    Clément E; Mesini PJ; Pattus F; Schalk IJ
    Biochemistry; 2004 Jun; 43(24):7954-65. PubMed ID: 15196040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron transport and serum resistance in Pseudomonas aeruginosa.
    Cox CD
    Antibiot Chemother (1971); 1985; 36():1-12. PubMed ID: 3159335
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluorescent Pseudomonas mainly produce the dihydro form of pyoverdine at low specific growth rate.
    Jacques P; Ongena M; Bernard F; Fuchs R; Budzikiewicz H; Thonart P
    Lett Appl Microbiol; 2003; 36(5):259-62. PubMed ID: 12680934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin.
    Döring G; Pfestorf M; Botzenhart K; Abdallah MA
    Infect Immun; 1988 Jan; 56(1):291-3. PubMed ID: 3121514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Siderophore presence in sputa of cystic fibrosis patients.
    Haas B; Kraut J; Marks J; Zanker SC; Castignetti D
    Infect Immun; 1991 Nov; 59(11):3997-4000. PubMed ID: 1834571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species.
    Meyer JM
    Arch Microbiol; 2000 Sep; 174(3):135-42. PubMed ID: 11041343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 15. Alginate production by the mucoid Pseudomonas aeruginosa associated with cystic fibrosis.
    Gill JF; Deretic V; Chakrabarty AM
    Microbiol Sci; 1987 Oct; 4(10):296-9. PubMed ID: 3155272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.
    Van Devanter DR
    Respiration; 2007; 74(3):356; author reply 357. PubMed ID: 17204830
    [No Abstract]   [Full Text] [Related]  

  • 17. Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung.
    Musk DJ; Hergenrother PJ
    J Appl Microbiol; 2008 Aug; 105(2):380-8. PubMed ID: 18284482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pyocyanin in Pseudomonas aeruginosa infection.
    Lau GW; Hassett DJ; Ran H; Kong F
    Trends Mol Med; 2004 Dec; 10(12):599-606. PubMed ID: 15567330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
    Winstanley C; Fothergill JL
    FEMS Microbiol Lett; 2009 Jan; 290(1):1-9. PubMed ID: 19016870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.
    Hassett DJ; Sutton MD; Schurr MJ; Herr AB; Caldwell CC; Matu JO
    Trends Microbiol; 2009 Mar; 17(3):130-8. PubMed ID: 19231190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.